Sugammadex hameln 100 mg/ml oplossing voor injectieNaloxon HCl Accord 04 mg/mloplossing voor injectie / infusie in een voorgevulde spuitANEXATE 05 mg/5 mlsolution injectable (I.V.)REMIMAZOLAMSufentanil Viatris 5 microgram/ml oplossing voor injectieEsmeron 10 mg/mloplossing voor injectie
Eligibility
Age group
18-64 years
Sex
Female, Male
Primary endpoint
Time to the return of spontaneous breathing
Endpoint detail
Time to opening the eyes, Time to return of airway reflexes (swallow-ing, coughing), Respiratory effects (saturation, respiratory rate, capnography), Hemodynamic effects (blood pressure, heart rate), Bispectral Index Score (BIS), Neuromuscular block depth, Physician satisfaction, Total time to emerge from anaesthesia (to-tally awake, as before induction)
Official registry record
This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.